Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia

Texto completo
Autor(es):
Attux, Ceclia [1] ; Martini, Larissa C. [1] ; Elkis, Helio [2] ; Tamai, Sergio [3] ; Freirias, Andrea [3] ; Miquelutti Camargo, Maria das Gracas [2] ; Mateus, Mario Dinis [1] ; Mari, Jair de Jesus [1] ; Reis, Andre F. [4] ; Bressan, Rodrigo A. [1]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Univ Fed Sao Paulo, Dept Psychiat, BR-04044000 Sao Paulo - Brazil
[2] Univ Sao Paulo, Med School, Dept & Inst Psychiat, BR-05403010 Sao Paulo - Brazil
[3] CAISM Ctr Atencao Integrada Saude Mental Irmandad, BR-04017030 Sao Paulo - Brazil
[4] Univ Fed Sao Paulo UNIFESP, Dept Med, Div Endocrinol, BR-04039002 Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: BMC Psychiatry; v. 13, FEB 18 2013.
Citações Web of Science: 25
Resumo

Background: Patients with schizophrenia have lower longevity than the general population as a consequence of a combination of risk factors connected to the disease, lifestyle and the use of medications, which are related to weight gain. Methods: A multicentric, randomized, controlled-trial was conducted to test the efficacy of a 12-week group Lifestyle Wellness Program (LWP). The program consists of a one-hour weekly session to discuss topics like dietary choices, lifestyle, physical activity and self-esteem with patients and their relatives. Patients were randomized into two groups: standard care (SC) and standard care plus intervention (LWP). Primary outcome was defined as the weight and body mass index (BMI). Results: 160 patients participated in the study (81 in the intervention group and 79 in the SC group). On an intent to treat analysis, after three months the patients in the intervention group presented a decrease of 0.48 kg (CI 95% - 0.65 to 1.13) while the standard care group showed an increase of 0.48 kg (CI 95% 0.13 to 0.83; p=0.055). At six-month follow-up, there was a significant weight decrease of -1.15 kg, (CI 95% -2.11 to 0.19) in the intervention group compared to a weight increase in the standard care group (+0.5 kg, CI 95% -0.42-1.42, p=0.017). Conclusion: In conclusion, this was a multicentric randomized clinical trial with a lifestyle intervention for individuals with schizophrenia, where the intervention group maintained weight and presented a tendency to decrease weight after 6 months. It is reasonable to suppose that lifestyle interventions may be important long-term strategies to avoid the tendency of these individuals to increase weight. Clinicaltrials.gov identifier: NCT01368406 (AU)

Processo FAPESP: 07/00464-6 - Intervenção não farmacológica para manejo do ganho de peso em pacientes com transtornos mentais persistentes: ensaio clínico multicêntrico, controlado, randomizado
Beneficiário:Rodrigo Affonseca Bressan
Modalidade de apoio: Auxílio à Pesquisa - Regular